Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

CD24Fc for the Prevention of Acute GVHD Following Myeloablative HSCT (CATHY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04095858
Recruitment Status : Not yet recruiting
First Posted : September 19, 2019
Last Update Posted : November 20, 2019
Sponsor:
Information provided by (Responsible Party):
OncoImmune, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 30, 2023
Estimated Study Completion Date : December 30, 2024